Triomics
Building AI infrastructure to turn complex cancer records into structured intelligence
$22MSeries B
Role not disclosedOV
Oncology Ventures
Activity from announced rounds
Activity in this selectionUnited States · May 31, 2026 · May 1, 2026
- Rounds participated in
- 2
- Confirmed lead rounds
- — 2 roles undisclosed
- New companies
- 2 First participation on record · 0 follow-on
- Funding in participating rounds
- $26.5M 2 disclosed · full round size, not this investor’s share
By stage
By primary sector
By country
Rounds
2 in this selectionModicus Prime
Builds AI compliance software enabling audit-ready AI deployment for pharmaceutical and regulated industries
$4.5MUndisclosed
Role not disclosed